This Article Full Text Full Text (PDF) Supplemental Research Data Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Natsoulis, G. Articles by Jarnagin, K. Search for Related Content PubMed PubMed Citation Articles by Natsoulis, G. Articles by Jarnagin, K. Social Bookmarking                   What's this?

Methods

Classification of a large microarray data set: Algorithm comparison and analysis of drug signatures

¹ Iconix Pharmaceuticals, Mountain View, California 94043, USA ² Dept. Electrical Engineering and Computer Sciences, University of California, Berkeley, Berkeley, California 94720, USA ³ SPSS, Chicago, Illinois 60606, USA

A large gene expression database has been produced that characterizes the gene expression and physiological effects of hundreds of approved and withdrawn drugs, toxicants, and biochemical standards in various organs of live rats. In order to derive useful biological knowledge from this large database, a variety of supervised classification algorithms were compared using a 597-microarray subset of the data. Our studies show that several types of linear classifiers based on Support Vector Machines (SVMs) and Logistic Regression can be used to derive readily interpretable drug signatures with high classification performance. Both methods can be tuned to produce classifiers of drug treatments in the form of short, weighted gene lists which upon analysis reveal that some of the signature genes have a positive contribution (act as "rewards" for the class-of-interest) while others have a negative contribution (act as "penalties") to the classification decision. The combination of reward and penalty genes enhances performance by keeping the number of false positive treatments low. The results of these algorithms are combined with feature selection techniques that further reduce the length of the drug signatures, an important step towards the development of useful diagnostic biomarkers and low-cost assays. Multiple signatures with no genes in common can be generated for the same classification end-point. Comparison of these gene lists identifies biological processes characteristic of a given class.

Article and publication are at http://www.genome.org/cgi/doi/10.1101/gr.2807605.

⁴ Corresponding author.
E-mail gnatsoulis{at}iconixpharm.com; fax (650) 567-5540.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. R. Fielden, R. Brennan, and J. Gollub A Gene Expression Biomarker Provides Early Prediction and Mechanistic Assessment of Hepatic Tumor Induction by Nongenotoxic Chemicals Toxicol. Sci., September 1, 2007; 99(1): 90 - 100. [Abstract] [Full Text] [PDF]

				M. T. Martin, R. J. Brennan, W. Hu, E. Ayanoglu, C. Lau, H. Ren, C. R. Wood, J. C. Corton, R. J. Kavlock, and D. J. Dix Toxicogenomic Study of Triazole Fungicides and Perfluoroalkyl Acids in Rat Livers Predicts Toxicity and Categorizes Chemicals Based on Mechanisms of Toxicity Toxicol. Sci., June 1, 2007; 97(2): 595 - 613. [Abstract] [Full Text] [PDF]

				J. Lamb, E. D. Crawford, D. Peck, J. W. Modell, I. C. Blat, M. J. Wrobel, J. Lerner, J.-P. Brunet, A. Subramanian, K. N. Ross, et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science, September 29, 2006; 313(5795): 1929 - 1935. [Abstract] [Full Text] [PDF]

				S. Tugendreich, C. I. Pearson, J. Sagartz, K. Jarnagin, and K. Kolaja NSAID-Induced Acute Phase Response is Due to Increased Intestinal Permeability and Characterized by Early and Consistent Alterations in Hepatic Gene Expression Toxicol Pathol, February 1, 2006; 34(2): 168 - 179. [Abstract] [PDF]

				D. R. Boverhof and T. R. Zacharewski Toxicogenomics in Risk Assessment: Applications and Needs Toxicol. Sci., February 1, 2006; 89(2): 352 - 360. [Abstract] [Full Text] [PDF]

				M. R. Fielden, B. P. Eynon, G. Natsoulis, K. Jarnagin, D. Banas, and K. L. Kolaja A Gene Expression Signature that Predicts the Future Onset of Drug-Induced Renal Tubular Toxicity Toxicol Pathol, October 1, 2005; 33(6): 675 - 683. [Abstract] [PDF]